Evaluation and Management of Bing-Neel Syndrome

Publication date

2023-08

Authors

Schep, Sarah J
Vos, Josephine M I
Minnema, Monique C.ORCID 0000-0002-3139-8379ISNI 0000000394782842

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

Bing-Neel syndrome is a rare manifestation of Waldenström macroglobulinemia (WM), which is caused by infiltration of the malignant lymphoplasmacytic cells in the central nervous system. Patients can present with a diverse range of neurologic symptoms, and differentiation with other comorbidities seen in WM, such as immunoglobulin M-related polyneuropathy, can be challenging. Both the rarity of this disorder and the heterogeneity of the clinical presentation often cause a significant diagnostic delay with the risk of permanent neurologic damage. This review summarizes current knowledge regarding diagnosis, treatment and prognosis of Bing-Neel syndrome.

Keywords

Bing–Neel syndrome, Central nervous system, Cerebrospinal fluid, MRI, Waldenström macroglobulinemia, Taverne, Hematology, Oncology, Review, Journal Article

Citation

Schep, S J, Vos, J M I & Minnema, M C 2023, 'Evaluation and Management of Bing-Neel Syndrome', Hematology/oncology clinics of North America, vol. 37, no. 4, pp. 777-786. https://doi.org/10.1016/j.hoc.2023.04.008